ContextVision sees strong sales, continues focus on launch of AI-based digital pathology
Stockholm - April 25, 2019 - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, reported strong sales in Q1, reaching 21.1 MSEK, 9% higher than the first quarter last year. The company reports positive feedback from user tests within digital pathology and continues to proceed with product development for this fast-growing market. Securing long-term businessTwo new, three-year contracts were signed with two of ContextVision's key customers in Asia and in the U.S. Overall, the company reports strong first quarter sales in